Showing results (641-650 of 660) with videos related to
Sort By:
Pageof 66
Lung Cancer (Amsterdam, Netherlands)|December 20, 2017
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life dataElizabeth Dudnik, Mor Moskovitz, Sameh Daher, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 4, 2018
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point InhibitorsElizabeth Dudnik, Nir Peled, Hovav Nechushtan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2012
Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumorsSuzanne Leijen, Mark R Middleton, Patricia Tresca, et al.International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study GroupJohn A Kalapurakal, Sierra M Li, Norman E Breslow, et al.British Journal of Haematology|September 27, 2014
Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemiaMarc R Mansour, Casie Reed, Amy R Eisenberg, et al.Clinical Lung Cancer|May 8, 2019
Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life CohortElizabeth Dudnik, Jair Bar, Nir Peled, et al.Leukemia|April 10, 2012
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemiaC Palmi, E Vendramini, D Silvestri, et al.Clinical and Experimental Rheumatology|May 19, 2026
Semen analysis of patients with psoriatic arthritis, axial spondyloarthritis and healthy controlsKatya Meridor, Shimi Barda, Ofir Elalouf, et al.Journal of the American Chemical Society|December 20, 2015
Detection of Pathogenic Biofilms with Bacterial Amyloid Targeting Fluorescent Probe, CDy11Jun-Young Kim, Srikanta Sahu, Yin-Hoe Yau, et al.Blood|December 8, 2009
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study GroupLibi Hertzberg, Elena Vendramini, Ithamar Ganmore, et al.Pageof 66